E-LIB Suche - Ergebnisse für: Bacon, Tamar E

1

Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐..:

Kister, Ilya ; Curtin, Ryan ; Piquet, Amanda L....
Annals of Clinical and Translational Neurology. 11 (2024) 7 - p. 1750-1764 , 2024

Link: https://doi.org/10.1002/..

2

No Increase in Symptoms Toward the End of the Ocrelizumab I..:

Kister, Ilya ; Oh, Cheongeun ; Douglas, Elizabeth A....
Neurology Clinical Practice. 13 (2023) 5 - p. , 2023

Link: https://doi.org/10.1212/..

3

Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Mu..:

Kister, Ilya ; Patskovsky, Yury ; Curtin, Ryan...
Annals of Neurology. 91 (2022) 6 - p. 782-795 , 2022

Link: https://doi.org/10.1002/..

4

Multiple Sclerosis Severity Score (MSSS) improves the accur..:

Kalincik, Tomas ; Kister, Ilya ; Bacon, Tamar E...
Multiple Sclerosis Journal. 28 (2022) 11 - p. 1752-1761 , 2022

Link: https://doi.org/10.1177/..

5

Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS..:

Kister, Ilya ; Curtin, Ryan ; Pei, Jinglan...
Annals of Clinical and Translational Neurology. 9 (2022) 10 - p. 1643-1659 , 2022

Link: https://doi.org/10.1002/..

6

Adverse childhood experiences predict reaction to multiple ..:

Eilam-Stock, Tehila ; Links, Jon ; Khan, Nabil Z....
Health Psychology Open. 8 (2021) 2 - p. 205510292110528 , 2021

Link: https://doi.org/10.1177/..

7

Effectiveness of alternative dose fingolimod for multiple s..:

Longbrake, Erin E. ; Kantor, Daniel ; Pawate, Siddharama...
Neurology Clinical Practice. 8 (2018) 2 - p. 102-107 , 2018

Link: https://doi.org/10.1212/..

8

Short-term disability progression in two multiethnic multip..:

Kister, Ilya ; Bacon, Tamar E. ; Cutter, Gary R.
Therapeutic Advances in Neurological Disorders. 11 (2018) - p. 175628641879361 , 2018

Link: https://doi.org/10.1177/..

9

Sound Lateralization Test Distinguishes Unimpaired MS Patie..:

Bacon, Joshua H. ; Kister, Ilya ; Bacon, Tamar E....
Multiple Sclerosis International. 2014 (2014) - p. 1-5 , 2014

Link: https://doi.org/10.1155/..

10

Disability in multiple sclerosis: A reference for patients ..:

Kister, Ilya ; Chamot, Eric ; Salter, Amber R....
Neurology. 80 (2013) 11 - p. 1018-1024 , 2013

Link: https://doi.org/10.1212/..

11

Increasing age at disability milestones among MS patients i..:

Kister, Ilya ; Chamot, Eric ; Cutter, Gary...
Journal of the Neurological Sciences. 318 (2012) 1-2 - p. 94-99 , 2012

Link: https://doi.org/10.1016/..

12

No Increase in Symptoms Toward the End of the Ocrelizumab I..:

Kister, Ilya ; Oh, Cheongeun ; Douglas, Elizabeth A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479935/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Mu..:

Kister, Ilya ; Patskovsky, Yury ; Curtin, Ryan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082484/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Multiple Sclerosis Severity Score (MSSS) improves the accur..:

Kalincik, Tomas ; Kister, Ilya ; Bacon, Tamar E...
boreal:276417. , 2022

Link: http://hdl.handle.net/20..

15

Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS..:

Kister, Ilya ; Curtin, Ryan ; Pei, Jinglan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538694/. , 2022

Link: http://www.ncbi.nlm.nih...